Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infection

Reena Mukhiya,Wim A. Fleischmann,Jessica R Loughland,Jo-Anne Chan,Fabian de Labastida Rivera,Dean Andrew,James G Beeson,James S McCarthy,Bridget Barber,J. Alejandro Lopez,Christian Engwerda,Richard Thomson-Luque,Michelle J Boyle
DOI: https://doi.org/10.1101/2024.04.28.591548
2024-08-04
Abstract:Human immune responses to infection and vaccination are heterogenous, driven by multiple factors including genetics, environmental exposures and personal infection histories. For malaria caused by Plasmodium falciparum parasites, host factors that impact on humoral immunity are poorly understood. We investigated the role of latent cytomegalovirus (CMV) on the host immune response to malaria using blood stage P. falciparum Controlled Human Malaria Infection (CHMI) and in a MSP1 vaccine Phase 1a clinical trial. CMV seropositivity was associated with reduced induction of parasite specific antibodies following malaria infection and vaccination. During infection, reduced antibody induction was associated with modifications to the T -follicular helper (Tfh) cell compartment. CMV seropositivity was associated with a skew towards Tfh1 cell subsets before and after malaria infection, and reduced activation of Tfh2 cells. Protective Tfh2 cell activation was only associated with antibody development in CMV seronegative individuals, and a higher proportion of Tfh1 cells was associated with lower antibody development in CMV seropositive individuals. During MSP1 vaccination, reduced antibody induction in CMV seropositive individuals was associated with CD4 T cell expression of terminal differentiation marker CD57. These findings are particularly relevant for malaria endemic regions where CMV infection is acquired early in life and may modify immunity to malaria gained during infection or vaccination.
Immunology
What problem does this paper attempt to address?